Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/DRKS00025759
DRKS00025759RecruitingNot Applicable

Intravenous immunoglobulin (IVIg)- impact of serum IgG peak-through differences for maintaining anti-inflammatory pathways in CIDP

Grifols Deutschland GmbH0 sites50 target enrollmentStarted: July 7, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
50
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • •Confirmed CIDP with sensory and/or motor deficits treated with either IVIg or SCIg. Furthermore, written informed consent is required.

Exclusion Criteria

  • •Underaged and/or non legally-competent persons, as well as subjects not providing written informed consent for study participation are excluded from the study. Furthermore, therapy with monocloncal antibodies, corticosteroids or immunosuppressants have to be excluded.

Investigators

Similar Trials

Recruiting
Phase 2
The effect of Intravenous immunoglobulin on COVID-19 infectio
IRCT20200418047116N1Gonabad University of Medical Sciences20
Completed
Not Applicable
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL)Acute lymphoblastic leukemia
JPRN-UMIN000015179agoya University Graduate School of Medicine30
Completed
Not Applicable
Effect of intravenous immunoglobulin (IVIG) in pregnant women with refractory obstetric antiphospholipid syndrome: A prospective single-arm interventional studyantiphospholipid syndrome
JPRN-UMIN000013496ational Center for Child Health and Development8
Completed
Not Applicable
Comparison of the effect of Intravenous immunoglobulin and rhophylacIdiopathic thrombocytopenic purpura.Idiopathic thrombocytopenic purpura (Evans syndrome)
IRCT2012102811289N1Arak University of Medical Sciences, Vice Chancellor for Research60
Completed
Not Applicable
The No IntraCranial Haemorrhage (NOICH) StudyFoetal or neonatal alloimmune thrombocytopeniaPregnancy and ChildbirthOther perinatal haematological disorders
ISRCTN29462550eiden University Medical Centre (LUMC) (Netherlands)212